Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|
Revenue | $26.7M | $82.6M | $148.8M | $271.9M | $526.9M | $872.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hims & Hers Health, Inc.'s last 12-month Revenue is $1,242.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Hims & Hers Health, Inc.'s Revenue growth was 56.7%. The average annual Revenue growth rates for Hims & Hers Health, Inc. have been 93.7% over the past three years, 84.7% over the past five years.
Over the last year, Hims & Hers Health, Inc.'s Revenue growth was 56.7%, which is higher than industry growth of (0.2%). It indicates that Hims & Hers Health, Inc.'s Revenue growth is Good.